Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet R Nicholson

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Handbook of Experimental Pharmacology|September 22, 2019
Minimum Information in In Vivo ResearchPatrizia Voehringer, Janet R Nicholson
Brain and Neuroscience Advances|March 14, 2020
The research domain criteria framework in drug discovery for neuropsychiatric diseases: focus on negative valenceJanet R Nicholson, Bernd Sommer
Annual Review of Pharmacology and Toxicology|September 28, 2006
The obesity epidemic: current and future pharmacological treatmentsKarl G Hofbauer, Janet R Nicholson, Olivier Boss
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 2006
Insufficient sleep reversibly alters bidirectional synaptic plasticity and NMDA receptor functionCaroline Kopp, Fabio Longordo, Janet R Nicholson, et al.
Inflammopharmacology|January 3, 2019
Establishment and characterisation of a stavudine (d4T)-induced rat model of antiretroviral toxic neuropathy (ATN) using behavioural and pharmacological methodsAndy Kuo, Janet R Nicholson, Laura Corradini, et al.
Biomolecules|July 2, 2021
Assessment of the Anti-Allodynic and Anti-Hyperalgesic Efficacy of a Glycine Transporter 2 Inhibitor Relative to Pregabalin, Duloxetine and Indomethacin in a Rat Model of Cisplatin-Induced Peripheral NeuropathyAndy Kuo, Laura Corradini, Janet R Nicholson, et al.
Clinical and Experimental Pharmacology & Physiology|July 21, 2020
Assessment of the anti-hyperalgesic efficacy of J-2156, relative to clinically available analgesic/adjuvant agents in a rat model of mild to moderate chronic mechanical low back pain (LBP)Andy Kuo, Jacintha Lourdesamy, Janet R Nicholson, et al.
Peptides|November 9, 2005
Cardiovascular responses to melanocortin 4-receptor stimulation in conscious unrestrained normotensive ratsUlrich Nordheim, Janet R Nicholson, Karol Dokladny, et al.
Clinical and Experimental Pharmacology & Physiology|May 22, 2018
Comparative analgesic efficacy of pregabalin administered according to either a prevention protocol or an intervention protocol in rats with cisplatin-induced peripheral neuropathyFelicity Y Han, Andy Kuo, Janet R Nicholson, et al.
Pharmacological Reports : PR|July 28, 2020
Assessment of the anti-allodynic efficacy of a glycine transporter 2 inhibitor relative to pregabalin and duloxetine in a rat model of prostate cancer-induced bone painMohammad Zafar Imam, Andy Kuo, Janet R Nicholson, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Handbook of Experimental Pharmacology|September 22, 2019
Minimum Information in In Vivo ResearchPatrizia Voehringer, Janet R Nicholson
Brain and Neuroscience Advances|March 14, 2020
The research domain criteria framework in drug discovery for neuropsychiatric diseases: focus on negative valenceJanet R Nicholson, Bernd Sommer
Annual Review of Pharmacology and Toxicology|September 28, 2006
The obesity epidemic: current and future pharmacological treatmentsKarl G Hofbauer, Janet R Nicholson, Olivier Boss
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 2006
Insufficient sleep reversibly alters bidirectional synaptic plasticity and NMDA receptor functionCaroline Kopp, Fabio Longordo, Janet R Nicholson, et al.
Inflammopharmacology|January 3, 2019
Establishment and characterisation of a stavudine (d4T)-induced rat model of antiretroviral toxic neuropathy (ATN) using behavioural and pharmacological methodsAndy Kuo, Janet R Nicholson, Laura Corradini, et al.
Biomolecules|July 2, 2021
Assessment of the Anti-Allodynic and Anti-Hyperalgesic Efficacy of a Glycine Transporter 2 Inhibitor Relative to Pregabalin, Duloxetine and Indomethacin in a Rat Model of Cisplatin-Induced Peripheral NeuropathyAndy Kuo, Laura Corradini, Janet R Nicholson, et al.
Clinical and Experimental Pharmacology & Physiology|July 21, 2020
Assessment of the anti-hyperalgesic efficacy of J-2156, relative to clinically available analgesic/adjuvant agents in a rat model of mild to moderate chronic mechanical low back pain (LBP)Andy Kuo, Jacintha Lourdesamy, Janet R Nicholson, et al.
Peptides|November 9, 2005
Cardiovascular responses to melanocortin 4-receptor stimulation in conscious unrestrained normotensive ratsUlrich Nordheim, Janet R Nicholson, Karol Dokladny, et al.
Clinical and Experimental Pharmacology & Physiology|May 22, 2018
Comparative analgesic efficacy of pregabalin administered according to either a prevention protocol or an intervention protocol in rats with cisplatin-induced peripheral neuropathyFelicity Y Han, Andy Kuo, Janet R Nicholson, et al.
Pharmacological Reports : PR|July 28, 2020
Assessment of the anti-allodynic efficacy of a glycine transporter 2 inhibitor relative to pregabalin and duloxetine in a rat model of prostate cancer-induced bone painMohammad Zafar Imam, Andy Kuo, Janet R Nicholson, et al.
Pageof 3